Stay updated on Expanded Access to Upadacitinib Clinical Trial
Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedA new revision label v3.4.3 was added and the v3.4.2 revision label was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedA new Revision: v3.4.2 has been added, and the previous Notice about a lapse in government funding (Revision: v3.4.1) has been removed. These updates are administrative and do not affect the core study information or accessibility of the expanded access program. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check66 days agoChange DetectedNew government funding status notice is displayed at the top of the page. The Eligibility section was updated with new Exclusion Criteria (There are other suitable treatment options; the participant qualifies for ongoing clinical trials) and a previously listed Inclusion Criteria item was removed.SummaryDifference1%

- Check73 days agoChange DetectedChanges are limited to page metadata and UI labels, including a glossary toggle, updated QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted), a No FEAR Act notice, and a revision to version 3.4.0, with older QC labeling and v3.3.4 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4 detected; page content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.